Star Health And Allied Insurance Company Limited has informed the Exchange about Investor Presentation

Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsInvestor Communications View source PDF

STARHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.9%1-day move

₹516.35

prior close

₹545.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-0.3-0.2-0.2+1.9+0.8+0.1+0.9+0.3+0.5+1.2+1.9+13.7—

Up moveDown movePending

AI summary

Star Health reported FY26 PAT of ₹911 Crore, up 16% from ₹787 Crore in FY25. The combined ratio improved significantly to 98.8% from 101.1% (236 bps improvement), driven by a reduction in loss ratio to 68.7% from 70.7%. Normalised PAT (excluding market volatility) grew 45% to ₹1,222 Crore, while underwriting profit turned positive at ₹206 Crore versus a loss of ₹165 Crore previously. GWP grew 16% YoY to ₹20,369 Crore, with retail fresh GWP up 38% at ₹4,567 Crore. Q4 FY26 showed a loss of ₹55 Crore due to ₹558 Crore mark-to-market investment losses amid market volatility, though the combined ratio improved to 95.7%. Investment yield declined to 5.8% from 7.6% due to adverse market conditions.

Likely market impact

The turnaround in underwriting profitability and improvement in combined ratio are positive signals for shareholders. However, the Q4 loss due to investment mark-to-market losses and declining investment yields may weigh on near-term sentiment. The strong growth in retail business and proprietary channels demonstrates business resilience.